entax-20 20 mg tablet
ambica international corporation; distributor: globo asiatico ent. inc. - tamoxifen (as citrate) - tablet - 20 mg
tezoxil 3.5mg powder for solution fo injection (iv/sc)
ambica international crop.; distributor: globo asiatico ent. inc. - bortezomib - powder for solution fo injection (iv/sc) - 3.5mg
globomin iv 1 v. inj.
panacea - inj. - 1 v.
allergenic extract
antigen laboratories, inc. - chaetomium globosum (unii: 5016wb8b8a) (chaetomium globosum - unii:5016wb8b8a) - chaetomium globosum 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.
qi chuan hua tan san
tabib wee hong - rhizoma arisaema erubescens; herba ardisia japonica; folium eriobotrya japonica.; flos tussilago farfara .; flos gomphrena globosa; radix platycodon grandiflorum; bulbus fritillaria cirrhosa -
finalgon ointment
globopharm pharmazeutische produktions-und handels gmbh. - nonivamide, nicoboxil - ointment - 4mg/g+ 25mg/g
fabrazyme ® 35mg (agalsidase beta)
sanofi-aventis singapore pte. ltd. - agalsidase beta - injection, powder, for solution - 37.0mg/35mg vial - agalsidase beta 37.0mg/35mg vial
fabrazyme ® 5mg (agalsidase beta)
sanofi-aventis singapore pte. ltd. - agalsidase beta - injection, powder, for solution - 5.5mg/5mg vial - agalsidase beta 5.5mg/5mg vial
apparent chainsaw 250 herbicide
titan ag pty ltd - hexazinone - soluble concentrate - hexazinone triazine-triazinones active 250.0 g/l - herbicide
efavirenz/emtricitabine/tenofovir disoproxil zentiva
zentiva k.s. - efavirenz, emtricitabine, tenofovir disoproxil, phosphate - hiv infections - antivirals for systemic use, - efavirenz/emtricitabine/tenofovir disoproxil zentiva is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil. it is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults aged 18 years and over with virologic suppression to hiv-1 rna levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harboured virus strains with mutations conferring significant resistance to any of the three components contained in efavirenz/emtricitabine/tenofovir disoproxil zentiva prior to initiation of their first antiretroviral treatment regimen., the demonstration of the benefit of the combination efavirenz/emtricitabine/tenofovir disoproxil is primarily based on 48-week data from a clinical study in which patients with stable virologic suppression on a combination antiretroviral therapy changed to efavir